Risk for falls higher in adjusted analysis for individuals with type 1 and type 2 diabetes
TUESDAY, Sept. 22, 2020 (HealthDay News) — Individuals with diabetes have an increased risk for falls, according to a study presented at the annual meeting of the European Association for the Study of Diabetes, held virtually from Sept. 21 to 25.
Nicklas H. Rasmussen, from the Steno Diabetes Center at the North Jutland Aalborg University Hospital in Denmark, and colleagues identified 12,975 people with type 1 diabetes (T1D) and 407,009 with type 2 diabetes (T2D) to estimate the risk for falls and identify risk factors associated with falls. The cohort was divided into two groups with a separate age- and sex-matched control group.
The researchers found that the cumulative incidence of falls requiring hospital treatment was 13.3 and 11.9 percent in T1D and T2D patients, respectively. T1D and T2D were associated with a higher risk for falls in the adjusted analysis (hazard ratios, 1.33 and 1.19, respectively). In both groups, an increased risk for falls was seen in association with female gender (hazard ratios, 1.21 and 1.61 for groups 1 and 2, respectively); age older than 65 years (hazard ratios, 1.52 and 1.32, respectively); use of selective serotonin receptor inhibitors (hazard ratios, 1.35 and 1.32, respectively); use of opioids (hazard ratios, 1.15 and 1.09, respectively); and a history of alcohol abuse (hazard ratios, 1.77 and 1.88, respectively).
“Gaining information on risk factors for falls could guide the management of diabetes treatment i.e. choice of drugs, which enables us to improve treatment particularly in people with a high risk of falls and fractures associated with high mortality,” the authors write.
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Gap Found Between Awareness of Breast Cancer Risk and Risk-Reducing Behavior
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026
ASTRO Issues Guidance for Use of Radiation Therapy in Bladder Cancer
Higher Intake of Saturated, Animal Fats May Increase Mortality in Prostate Cancer
Adverse Pathological Features Do Not Predict Benefit of Hormone Therapy in Prostate Cancer